Literature DB >> 17985619

BGRT: biologically guided radiation therapy-the future is fast approaching!

Robert D Stewart1, X Allen Li.   

Abstract

Rapid advances in functional and biological imaging, predictive assays, and our understanding of the molecular and cellular responses underpinning treatment outcomes herald the coming of the long-sought goal of implementing patient-specific biologically guided radiation therapy (BGRT) in the clinic. Biological imaging and predictive assays have the potential to provide patient-specific, three-dimensional information to characterize the radiation response characteristics of tumor and normal structures. Within the next decade, it will be possible to combine such information with advanced delivery technologies to design and deliver biologically conformed, individualized therapies in the clinic. The full implementation of BGRT in the clinic will require new technologies and additional research. However, even the partial implementation of BGRT treatment planning may have the potential to substantially impact clinical outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17985619     DOI: 10.1118/1.2779861

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  11 in total

1.  Perspectives on stereotactic body radiotherapy for early-stage non-small cell lung cancer: a maturing treatment modality.

Authors:  Chunhui Han
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  An oxygen-consuming phantom simulating perfused tissue to explore oxygen dynamics and (19)F MRI oximetry.

Authors:  Steven H Ubert Baete; Jan Vandecasteele; Luc Colman; Wilfried De Neve; Yves De Deene
Journal:  MAGMA       Date:  2010-06-25       Impact factor: 2.310

3.  Artificial Intelligence in Radiation Therapy.

Authors:  Yabo Fu; Hao Zhang; Eric D Morris; Carri K Glide-Hurst; Suraj Pai; Alberto Traverso; Leonard Wee; Ibrahim Hadzic; Per-Ivar Lønne; Chenyang Shen; Tian Liu; Xiaofeng Yang
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-08-24

Review 4.  An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response.

Authors:  Benjamin Titz; Robert Jeraj
Journal:  Phys Med Biol       Date:  2008-08-01       Impact factor: 3.609

5.  On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function.

Authors:  Stephen R Bowen; Ryan T Flynn; Søren M Bentzen; Robert Jeraj
Journal:  Phys Med Biol       Date:  2009-02-13       Impact factor: 3.609

6.  Choline PET based dose-painting in prostate cancer--modelling of dose effects.

Authors:  Maximilian Niyazi; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2010-03-18       Impact factor: 3.481

7.  Adaptive IMRT using a multiobjective evolutionary algorithm integrated with a diffusion-invasion model of glioblastoma.

Authors:  C H Holdsworth; D Corwin; R D Stewart; R Rockne; A D Trister; K R Swanson; M Phillips
Journal:  Phys Med Biol       Date:  2012-11-29       Impact factor: 3.609

8.  Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.

Authors:  Wayne D Newhauser; Rui Zhang; Timothy G Jones; Annelise Giebeler; Phillip J Taddei; Robert D Stewart; Andrew Lee; Oleg Vassiliev
Journal:  Cancers (Basel)       Date:  2015-04-24       Impact factor: 6.639

9.  Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.

Authors:  Antonella Bufacchi; Barbara Nardiello; Roberto Capparella; Luisa Begnozzi
Journal:  Radiat Oncol       Date:  2013-07-04       Impact factor: 3.481

10.  Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.

Authors:  David Corwin; Clay Holdsworth; Russell C Rockne; Andrew D Trister; Maciej M Mrugala; Jason K Rockhill; Robert D Stewart; Mark Phillips; Kristin R Swanson
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.